Page last updated: 2024-12-05

nicotinamide mononucleotide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth

Description

Nicotinamide Mononucleotide: 3-Carbamoyl-1-beta-D-ribofuranosyl pyridinium hydroxide-5'phosphate, inner salt. A nucleotide in which the nitrogenous base, nicotinamide, is in beta-N-glycosidic linkage with the C-1 position of D-ribose. Synonyms: Nicotinamide Ribonucleotide; NMN. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID14180
CHEMBL ID610238
CHEBI ID16171
SCHEMBL ID105618
MeSH IDM0014835

Synonyms (65)

Synonym
einecs 214-136-5
unii-2kg6qx4w0v
2kg6qx4w0v ,
3-(aminocarbonyl)-1-(5-o-phosphono-beta-d-ribofuranosyl)pyridinium, inner salt
CHEBI:16171 ,
nmn zwitterion
3-carbamoyl-1-[5-o-(hydroxyphosphinato)-beta-d-ribofuranosyl]pyridinium
3-(aminocarbonyl)-1-(5-o-phosphonato-beta-d-ribofuranosyl)pyridinium
beta-nicotinamide ribose monophosphate
beta-nmn
3-carbamoyl-1-beta-d-ribofuranosylpyridinium hydroxide 5'-(dihydrogen phosphate) inner salt
pyridinium, 3-(aminocarbonyl)-1-(5-o-phosphono-beta-d-ribofuranosyl)-, inner salt
nicotinamide ribonucleotide
nicotinamide mononucleotide
NMN ,
beta-nicotinamide ribonucleotide
C00455
nicotinamide nucleotide
nicotinamide d-ribonucleotide
beta-nicotinamide d-ribonucleotide
1094-61-7
beta-nicotinamide mononucleotide
BMSE000260
nicotinamide ribonucleoside 5'-phosphate
CHEMBL610238
betanmn
bdbm50366763
nicotinamide ribotide
AKOS015896881
pyridinium, 3-(aminocarbonyl)-1-(5-o-phosphono-.beta.-d-ribofuranosyl)-, inner salt
.beta.-nmn
nmn [mi]
3-(aminocarbonyl)-1-(5-o-phosphono-.beta.-d-ribofuranosyl)pyridinium inner salt
.beta.-d-nmn
SCHEMBL105618
HY-F0004
CS-4996
((2r,3s,4r,5r)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen phosphate
AC-35057
3-carbamoyl-1-[(2r,3r,4s,5r)-5-[(hydrogen phosphonatooxy)methyl]-3,4-dihydroxyoxolan-2-yl]-1$l^{5}-pyridin-1-ylium
3-(aminocarbonyl)-1-(5-o-phosphono-beta-d-ribofuranosyl)pyridinium inner salt
J-002287
afae'a centa' nota inverted exclamation markafasa'a|afae'adaggeratrade markafa centa centasa nota em leadera inverted exclamation mark-nicotinamide mononucleotide
3-carbamoyl-1-[(2r,3r,4s,5r)-5-[(hydrogen phosphonatooxy)methyl]-3,4-dihydroxyoxolan-2-yl]-1??-pyridin-1-ylium
AS-59655
H11919
nicotinamidmononucleotid
DTXSID50911152
DAYLJWODMCOQEW-TURQNECASA-N
mfcd00038748
((2r,3s,4r,5r)-5-(3-carbamoylpyridinium-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen phosphate
Q21547155
b-nicotinamide mononucleotide
b-nm
[(2r,3s,4r,5r)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methylhydrogenphosphate
?-nicotinamidemononucleotide
CCG-267847
beta -nicotinamide mononucleotide
EX-A3534
-nm;nmn
-nicotinamide mononucleotide
ss-nmn
ss-nicotinamide mononucleotide
fa-nicotinamide mononucleotide
N1123

Research Excerpts

Overview

Nicotinamide mononucleotide (NMN) is a precursor of nicotinamide adenine dinucleotide, which plays an important role in cell redox homeostasis. It is a natural antioxidant approved as a nutritional supplement and food ingredient, but its protective role in silicosis remains unknown.

ExcerptReferenceRelevance
"Nicotinamide mononucleotide (NMN) is a precursor of nicotinamide adenine dinucleotide, which plays an important role in cell redox homeostasis."( Antioxidant effect of nicotinamide mononucleotide in tendinopathy.
Hoshino, Y; Inui, A; Kuroda, R; Kurosawa, T; Mifune, Y; Mukohara, S; Niikura, T; Nishimoto, H; Yamaura, K, 2022
)
1.76
"β-Nicotinamide mononucleotide (NMN) is an important precursor in the synthesis of nicotinamide adenine dinucleotide (NAD"( An artificial multi-enzyme cascade biocatalysis for biomanufacturing of nicotinamide mononucleotide from starch and nicotinamide in one-pot.
Li, Q; Meng, D; You, C, 2023
)
1.86
"Nicotinamide mononucleotide (NMN) is a nucleotide that is commonly recognized for its role as an intermediate of nicotinamide adenine dinucleotide (NAD"( Nicotinamide Mononucleotide Attenuates LPS-Induced Acute Lung Injury With Anti-Inflammatory, Anti-Oxidative and Anti-Apoptotic Effects.
Deng, XM; Li, HR; Li, P; Liu, Q; Tian, Y; Wang, JF; Zhu, CL, 2023
)
3.8
"Nicotinamide mononucleotide (NMN) is a natural antioxidant approved as a nutritional supplement and food ingredient, but its protective role in silicosis characterized by oxidative damage remains unknown. "( Nicotinamide Mononucleotide Ameliorates Silica-Induced Lung Injury through the Nrf2-Regulated Glutathione Metabolism Pathway in Mice.
Bao, Q; Chen, X; Du, W; Peng, L; Qian, R; Wang, L; Wang, M; Xie, Y; Yao, Y; Ye, T; Zhang, B; Zhang, L; Zhao, M, 2022
)
3.61
"Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis, and is widely used to replenish the levels of NAD+."( Nicotinamide mononucleotide attenuates glucocorticoid‑induced osteogenic inhibition by regulating the SIRT1/PGC‑1α signaling pathway.
Huang, RX; Tao, J, 2020
)
2.72
"Nicotinamide mononucleotide (NMN) is a key intermediate in the nicotinamide adenine dinucleotide (NAD+) biosynthesis. "( Characterization of Two NMN Deamidase Mutants as Possible Probes for an NMN Biosensor.
Amici, A; Camarca, A; Capo, A; D'Auria, S; Minazzato, G; Pennacchio, A; Raffaelli, N, 2021
)
2.06
"Nicotinamide mononucleotide (NMN) is a nucleotide that is most recognized for its role as an intermediate of nicotinamide adenine dinucleotide (NAD+) biosynthesis. "( Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential Molecule.
Chowdhury, S; Haque, S; Mehedi, I; Nahid, NA; Poddar, SK; Sifat, AE, 2019
)
3.4

Effects

Nicotinamide mononucleotide (NMN) has been recognized as a promising bio-active compound in relieving aging-related mitochondrial dysfunction. It has been shown to stimulate oxidative phosphorylation in mitochondria and to improve various pathologies.

ExcerptReferenceRelevance
"Nicotinamide mononucleotide (NMN) has beneficial effects in maintaining the cellular physiological functions."( Nicotinamide mononucleotide alleviates heat stress-induced oxidative stress and apoptosis in BMECs through reducing mitochondrial damage and endoplasmic reticulum stress.
Han, ZY; Li, SJ; Wang, XL; Xu, J; Zeng, HF, 2022
)
2.89
"β-Nicotinamide mononucleotide (NMN) has recently gained attention for a nutritional supplement because it is an intermediate in the biosynthesis of nicotinamide adenine dinucleotide (NAD"( Synthesis of Nicotinamide Mononucleotide from Xylose via Coupling Engineered Escherichia coli and a Biocatalytic Cascade.
Jantama, K; Kamkaew, A; Khunnonkwao, P; Lai, RY; Lasin, P; Ngivprom, U; Worakaensai, S, 2022
)
1.81
"Nicotinamide mononucleotide (NMN) has been reported to alleviate a variety of age-related diseases and has potential of regulating gut microbiota."( NMN alleviates radiation-induced intestinal fibrosis by modulating gut microbiota.
Huang, H; Ji, K; Liu, Q; Liu, Y; Wang, F; Zhang, M; Zhao, X, 2023
)
1.63
"Nicotinamide mononucleotide (NMN) has been recognized as a promising bio-active compound in relieving aging-related mitochondrial dysfunction. "( Preparation and evaluation of ovalbumin-fucoidan nanoparticles for nicotinamide mononucleotide encapsulation with enhanced stability and anti-aging activity.
Li, J; Li, Y; Sun, S; Tan, M; Xiang, S; Zhang, X; Zhou, C, 2023
)
2.59
"Nicotinamide mononucleotide (NMN) has been shown to stimulate oxidative phosphorylation in mitochondria and to improve various pathologies in patients and mouse disease models. "( Nicotinamide mononucleotide ameliorates the depression-like behaviors and is associated with attenuating the disruption of mitochondrial bioenergetics in depressed mice.
Fu, Z; Li, Z; Shen, Q; Xiao, Q; Xie, X; Xiong, Z; Yu, C; Zhou, J, 2020
)
3.44

Actions

ExcerptReferenceRelevance
"Nicotinamide mononucleotide (NMN) plays an important role in oxidative stress related diseases, but its role in AD is unclear."( Nicotinamide mononucleotide ameliorates DNFB-induced atopic dermatitis-like symptoms in mice by blocking activation of ROS-mediated JAK2/STAT5 signaling pathway.
Chen, L; Ding, H; Gao, JF; Luo, F; Meng, ZD; Tang, L; Zhang, YY, 2022
)
2.89

Treatment

ExcerptReferenceRelevance
"Pretreatment with nicotinamide mononucleotide significantly increased the NAD + level and alleviated the senescence of HASMCs, but did not change the expression level of nicotinamide phosphoribosyltransferase.Our study provides a complementary research platform between traditional cell culture and animal experiments to explore HASMC senescence in aortic aneurysms."( Nicotinamide Mononucleotide Alleviates Angiotensin II-Induced Human Aortic Smooth Muscle Cell Senescence in a Microphysiological Model.
Abudupataer, M; Lai, H; Li, J; Ming, Y; Wang, C; Xiang, B; Yin, X; Zhu, K, 2023
)
2.68

Toxicity

ExcerptReferenceRelevance
" However, whether Wld(S) can protect non-neuronal cells against toxic chemicals is largely unknown."( Wld(S) reduces paraquat-induced cytotoxicity via SIRT1 in non-neuronal cells by attenuating the depletion of NAD.
Chen, X; Liu, Y; Wang, T; Wu, D; Wu, J; Yu, Q; Zhai, Q; Zhou, X, 2011
)
0.37
" Moreover, no severe adverse events were observed during the study period."( Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women.
Fukamizu, Y; Kosaka, H; Sakurai, T; Sato, T; Shigekawa, A; Uchida, Y, 2022
)
1.03
" No safety issues, based on monitoring adverse events (AEs), laboratory and clinical measures, were found, and NMN supplementation was well tolerated."( The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.
Andhalkar, N; Avhad, G; Kumbhar, V; Lin, Z; Maier, AB; Pendse, S; Tao, R; Thasma, S; Vaidya, A; Yi, L, 2023
)
1.2

Bioavailability

ExcerptReferenceRelevance
" Similar effects are obtained by germ line deletion of major NAD-consuming enzymes, suggesting that the bioavailability of NAD is limiting for maximal oxidative capacity."( Increasing NAD synthesis in muscle via nicotinamide phosphoribosyltransferase is not sufficient to promote oxidative metabolism.
Agarwal, B; Baur, JA; Dávila, A; Davis, JG; Frederick, DW; Michan, S; Nakamaru-Ogiso, E; Puchowicz, MA, 2015
)
0.42

Dosage Studied

ExcerptRelevanceReference
" Nor did their 14CO2 production differ after intraperitoneal dosing with [methylene-14C]tryptophan."( Leucine excess and niacin status in rats.
Carpenter, KJ; Cook, NE, 1987
)
0.27
" We previously reported that an increased dosage of Sirt1 in pancreatic beta cells enhances glucose-stimulated insulin secretion (GSIS) and improves glucose tolerance in beta cell-specific Sirt1-overexpressing (BESTO) transgenic mice at 3 and 8 months of age."( Age-associated loss of Sirt1-mediated enhancement of glucose-stimulated insulin secretion in beta cell-specific Sirt1-overexpressing (BESTO) mice.
Imai, S; Mills, KF; Ramsey, KM; Satoh, A, 2008
)
0.35
" These data suggest that administration of NMN at a proper dosage has a strong protective effect against ischemic brain injury."( Nicotinamide mononucleotide inhibits post-ischemic NAD(+) degradation and dramatically ameliorates brain damage following global cerebral ischemia.
Kristian, T; Long, A; Owens, K; Park, JH, 2016
)
1.88
" The participants were randomized into four groups: the low dosage group (300 mg/day NMN), the medium dosage group (600 mg/day NMN), the high dosage group (1200 mg/day NMN), and the control group (placebo)."( Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study.
Hao, X; Hu, M; Liao, B; Wang, D; Zhang, X; Zhao, Y, 2021
)
2.06
" This randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial included 80 middle-aged healthy adults being randomized for a 60-day clinical trial with once daily oral dosing of placebo, 300 mg, 600 mg, or 900 mg NMN."( The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.
Andhalkar, N; Avhad, G; Kumbhar, V; Lin, Z; Maier, AB; Pendse, S; Tao, R; Thasma, S; Vaidya, A; Yi, L, 2023
)
1.2
" Dosing regimens and study durations vary greatly across interventions, and small sample sizes limit data interpretation of physiological outcomes."( Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions.
Craighead, DH; Freeberg, KA; Martens, CR; Seals, DR; Udovich, CC, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (10 Product(s))

Product Categories

Product CategoryProducts
Vitamins & Supplements8
Professional Supplements2

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
1Life Science NAD+ Longevity Blood Sugar Support -- 60 Veggie Caps1Life ScienceVitamins & SupplementsUrolithin A, Berberine HCl, Chromium, NAD +, NMN, Alpha-Lipoic Acid, Vanadium2024-11-29 10:47:42
1Life Science NAD+ Longevity Cardiovascular Support -- 60 Veggie Caps1Life ScienceVitamins & SupplementsApigenin, Fisetin, Vitamin B9, NAD +, Vitamin B3, NMN, Vitamin B6, Quercetin, Vitamin B62024-11-29 10:47:42
1Life Science NAD+ Longevity Cognition & Vision Support -- 60 Veggie Caps1Life ScienceVitamins & SupplementsApigenin, Lutein, NAD +, NMN, Zeaxanthin2024-11-29 10:47:42
1Life Science NMN+ Serum Platinum -- 1.7 oz1Life ScienceVitamins & Supplementscarbomer, vitamin E, vitamin E, nicotinamide mononucleotide, resveratrol, sodium hydroxide2024-11-29 10:47:42
Codeage Liposomal NMN + Resveratrol Quercetin TMG NAD+ Supplement -- 500 mg - 90 CapsulesCodeageProfessional SupplementsBetaine Anhydrous, NMN, Riboflavin, Vitamin B122024-11-29 10:47:42
Cymbiotika NMN + Trans-Resveratrol -- 60 CapsulesCymbiotikaVitamins & SupplementsNMN, Resveratrol2024-11-29 10:47:42
Double Wood Supplements NMN Nicotinamide Mononucleotide -- 250 mg - 60 CapsulesDouble Wood SupplementsProfessional SupplementsNicotinamide Mononucleotide2024-11-29 10:47:42
Nutri Ageless NMN Nicotinamide Mononucleotide -- 300 mg - 60 CapsulesNutriVitamins & SupplementsBeta-nicotinamide mononucleotide2024-11-29 10:47:42
Nutri NMN+ Max Strength Nicotinamide Mononucleotide -- 1000 mg - 60 Vegan CapsulesNutriVitamins & SupplementsBeta-nicotinamide Mononucleotide2024-11-29 10:47:42
Nutri NMN+ with Quercefit & Black Pepper -- 500 mg - 60 Vegan CapsulesNutriVitamins & SupplementsBeta-nicotinamide Mononucleotide2024-11-29 10:47:42

Roles (2)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
nicotinamide mononucleotide
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (9)

PathwayProteinsCompounds
Nicotinate and Nicotinamide Metabolism1434
NAD Metabolism1435
Nicotinate and Nicotinamide metabolism ( Nicotinate and Nicotinamide metabolism )2225
Nicotinamide D-ribonucleotide + ATP = NAD+ + Pyrophosphate ( Nicotinate and Nicotinamide metabolism )24
Nicotinamide D-ribonucleotide + Pyrophosphate = Nicotinamide + D-5-Phospho-ribosyl 1-diphosphate ( Nicotinate and Nicotinamide metabolism )14
The impact of Nsp14 on metabolism (COVID-19 Disease Map)084
NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence19
pyridine nucleotide cycling017
nicotinamide riboside salvage pathway06

Protein Targets (5)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Alcohol dehydrogenase E chainEquus caballus (horse)Ki10,000.00000.14122.89278.7000AID33858
Alcohol dehydrogenase S chainEquus caballus (horse)Ki10,000.00000.14122.89278.7000AID33858
Glyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)IC50 (µMol)500.00006.00007.33338.0000AID72741; AID72743
Metabotropic glutamate receptor 3Rattus norvegicus (Norway rat)Ki10,000.00000.00300.13400.4760AID74662
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (20)

Processvia Protein(s)Taxonomy
glutamate catabolic processGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
glutamine metabolic processGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
tricarboxylic acid metabolic processGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
microtubule cytoskeleton organizationGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
positive regulation of cytokine productionGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
glucose metabolic processGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
glycolytic processGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
negative regulation of endopeptidase activityGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
regulation of macroautophagyGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
negative regulation of translationGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
killing of cells of another organismGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
positive regulation of type I interferon productionGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
peptidyl-cysteine S-trans-nitrosylationGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
protein stabilizationGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
defense response to fungusGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
neuron apoptotic processGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
killing by host of symbiont cellsGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
antimicrobial humoral immune response mediated by antimicrobial peptideGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
cellular response to type II interferonGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (14)

Processvia Protein(s)Taxonomy
glutamate dehydrogenase (NAD+) activityGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
glutamate dehydrogenase [NAD(P)+] activityGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
glutamate dehydrogenase (NADP+) activityGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
ATP bindingGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
GTP bindingGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
identical protein bindingGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activityGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
protein bindingGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
microtubule bindingGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
aspartic-type endopeptidase inhibitor activityGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
peptidyl-cysteine S-nitrosylase activityGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
identical protein bindingGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
NADP bindingGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
NAD bindingGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
disordered domain specific bindingGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (17)

Processvia Protein(s)Taxonomy
mitochondrionGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
mitochondrial inner membraneGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
endoplasmic reticulumGlutamate dehydrogenase 1, mitochondrial Bos taurus (cattle)
nucleusGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
cytoplasmGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
lipid dropletGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
cytosolGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
plasma membraneGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
microtubule cytoskeletonGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
membraneGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
nuclear membraneGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
vesicleGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
intracellular membrane-bounded organelleGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
perinuclear region of cytoplasmGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
extracellular exosomeGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
GAIT complexGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
ribonucleoprotein complexGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
cytosolGlyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID72741Inhibitory concentration against Trypanosoma mexicana glyceraldehyde-3-phosphate dehydrogenase (GAPDH)2001Bioorganic & medicinal chemistry letters, Jan-22, Volume: 11, Issue:2
A disubstituted NAD+ analogue is a nanomolar inhibitor of trypanosomal glyceraldehyde-3-phosphate dehydrogenase.
AID74662In vitro inhibitory activity against bovine liver glutamate dehydrogenase (GDH)1990Journal of medicinal chemistry, Apr, Volume: 33, Issue:4
Dehydrogenase binding by tiazofurin anabolites.
AID72743Inhibitory concentration against rabbit muscle glyceraldehyde-3-phosphate dehydrogenase (GAPDH)2001Bioorganic & medicinal chemistry letters, Jan-22, Volume: 11, Issue:2
A disubstituted NAD+ analogue is a nanomolar inhibitor of trypanosomal glyceraldehyde-3-phosphate dehydrogenase.
AID106791In vitro inhibitory activity against pig heart cytoplasmic malate dehydrogenase (MDH); No data1990Journal of medicinal chemistry, Apr, Volume: 33, Issue:4
Dehydrogenase binding by tiazofurin anabolites.
AID99369In vitro inhibitory activity against pig heart lactate dehydrogenase (LDH); No data1990Journal of medicinal chemistry, Apr, Volume: 33, Issue:4
Dehydrogenase binding by tiazofurin anabolites.
AID33858In vitro inhibitory activity against horse liver Alcohol dehydrogenase1990Journal of medicinal chemistry, Apr, Volume: 33, Issue:4
Dehydrogenase binding by tiazofurin anabolites.
AID269132Inhibition of Escherichia coli KPR at 5 mM2006Journal of medicinal chemistry, Aug-10, Volume: 49, Issue:16
Probing hot spots at protein-ligand binding sites: a fragment-based approach using biophysical methods.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (495)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990152 (30.71)18.7374
1990's37 (7.47)18.2507
2000's51 (10.30)29.6817
2010's106 (21.41)24.3611
2020's149 (30.10)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials12 (2.37%)5.53%
Reviews32 (6.31%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other463 (91.32%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]